Frequent detection of hepatitis B core antibodies in heart transplant recipients without preceding hepatitis B infection

Transplantation Proceedings

Volumn 37, Issue 10, 2005, Pages 4522-4524

  Tenderich, G ^a   Zittermann, A ^a   Prohaska, W ^a   Wlost, S ^a   Fuchs, U ^a   Gursoy D ^a   Minami, K ^a   Koerfer, R ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; IMMUNOGLOBULIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HEART TRANSPLANTATION; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; MALE; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT;

EID: 29544439446     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.11.025     Document Type: Article

References (9)

1. H. Wedemeyer, K. Pethig, D. Wagner Long-term outcome of chronic hepatitis B in heart transplant recipients Transplantation 66 2003 1347
2. J.L. Wolf, H.A. Perkins, M.T. Schreeder The transplanted kidney as a source of hepatitis B infection Ann Intern Med 91 1979 412
3. M.K. Chan, W.K. Chasng Renal transplantation from HBsAg positive donors to HBsAg negative recipents Br Med J 297 1988 522
4. L.I. Lutwick, J.M. Sywassink, R.J. Corry The transmission of hepatitis B by renal transplantation 19 1983 317
5. J.A. Lowell, T.K. Howard, H.M. White Serological evidence of past hepatitis B infection in liver donor and hepatitis infection in liver allograft Lancet 345 1995 1084
6. J. Romer, J.J. Morgenthaler, R. Scherz Characterisation of various immunoglobulin preparations for intravenous application. I: Protein composition and antibody content Vox Sang 42 1982 62
7. P.A. Thurmann, C. Sonnenburg-Chatzopoulos, R. Lissner Pharmacokinetic characteristics and tolerability of a novel intravenous immunoglobulin preparation Eur J Clin Pharmacol 49 1995 237
8. M. Wahl, S. Hermodsson, H. Kjellman Recovery and turnover rate of hepatitis B immunoglobulin in volunteers Dev Biol Stand 54 1983 341
9. M. Berger, P.J. Pinciaro Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases J Clin Immunol 24 2004 389